Embed Size (px)
Citation preview
MONTHLY INTELLIGENCE | UPCOMING EVENTS | MEDIA DIRECTORY | CONFERENCES
MONTHLY HEALTHCARE NEWSLETTER - NOVEMBER 2019 A GLOBAL LEADER IN STRATEGIC HEALTHCARE COMMUNICATIONSLondon | New York | Boston | San Francisco
Visit www.consilium-comms.com for more intel
Consilium Strategic Communications is looking forward to hosting its Annual Healthcare Conference, in association with Stifel, Cooley and Citi. The invitation-only, half-day event will take place from 12pm on 19 November 2019, at the De Vere Grand Connaught, Rooms, 61-65 Great Queen St, London, WC2B 5DA.
The event, now an established fixture on the healthcare conference circuit, assembles high-quality speakers from across the international healthcare and investment communities to review
CONSILIUM STRATEGIC COMMUNICATIONS, STIFEL, COOLEY AND CITI
2019 ANNUAL HEALTHCARE CONFERENCE
7th Annual Healthcare Conference Towards a sustainable healthcare industry: commercialisation, cooperation & capital
key themes and challenges facing the sector today.
Following a keynote address from AstraZeneca's Shaun Grady, this year’s panels will look at the relationship between biotech and big pharma, the current landscape for companies seeking to access US capital and insights into the future of the healthcare industry. The event will conclude with a fireside chat with Sean Marett, Chief Business and Chief Commercial Officer of BioNTech, hosted by Denise Roland, Pharmaceuticals Reporter at the Wall Street Journal.
MONTHLY INTELLIGENCE
ANALYST MOVES – Michael Ruzic-Gauthier is leaving Berenberg – Olga Smolentseva has joined Bryan Garnier & Co.
– Sean Conroy is joining Jefferies
MEDIA MOVES – Rich Barbieri has joined the New York Times as Deputy Business Editor
– Ben Fidler has left Xconomy – Vantage’s Madeleine Armstrong is now on maternity leave
This is an invitation-only, free-to-attend event. Please email [email protected] if you would like to attend.
@ConsiliumHC
12:00pm – 1:00pm LUNCH AND NETWORKING
1:00pm – 1.15pm Welcome and introductions
1:15pm – 1:30pm Keynote address
SPEAKER: Shaun Grady, Vice-President Business Development Operations, AstraZeneca
1:30pm – 2:15pm Biotech versus Big Pharma – Who needs whom now?
PANELLISTS:Ben Adams, Editor, Fierce Biotech; Kate Bingham, Managing Partner, SV Health Investors; Sven Kili, Principal, Sven Kili Consulting; Dmitry Kuzmin, Managing Partner, 4BIO Capital; Jan Thirkettle, Chief Development Officer, Freeline Therapeutics
2:15pm – 3:00pm Update on capital markets – Is the US the promised land for healthcare financing?
PANELLISTS:John Dawson, Chief Executive Officer, Oxford Biomedica; Michel Detheux, Chief Executive Officer, iTeos Therapeutics; Eric Soyer, Chief Financial Officer & Chief Operating Officer, ERYTECH; Lisa Williams, EMEA Head of DR Investor Relations Advisory, Citi
3:00pm – 3.30pm BREAK
3.30pm – 4:15pm Healthcare 2.0 – What will the industry look like in 2020 and beyond?
PANELLISTS:Doug Doerfler, President and Chief Executive Officer, MaxCyte; Rabia Khan, Chief of Translational Medicine, Sensyne Health; Darragh Lyons, Chief Executive Officer, Malin; José Mesa, Partner, Alta Life Sciences; John Milad, Chief Executive Officer, Quanta
4.15pm – 5:00pm Fireside chat
INTERVIEWER: Denise Roland, Pharmaceuticals Reporter, Wall Street Journal
SPEAKER: Sean Marett, Chief Business and Chief Commercial Officer, BioNTech
5:00pm – 6:30pm NETWORKING DRINKS
Webcast Sponsor
If you would like to receive our Monday Healthcare Bulletin, which summarises all healthcare business news from the weekend, please contact:
– Achilles Therapeutics appointed Beverley Carr as CBO
– Arvelle Therapeutics GmbH appointed Petra Molan as SVP Commercial and Enrico Dolfini as VP Legal Counsel, effective 2 December
– Santhera Pharmaceuticals appointed Dario Eklund as CEO, effective 1 December 2019. Thomas Meier will continue as a Board Member and will chair the newly formed Board of Director’s Scientific Committee
– Summit Therapeutics plc announced that Valerie Andrews stepped down as a Non-Executive Director
– Vectura Group plc appointed Will Downie as CEO and Executive Director
– Amgen announced that David Meline will retire from his role as CFO and be replaced by Peter Griffith
– Avidity Biosciences appointed Sarah Boyce as CEO
– Bicycle Therapeutics appointed Nigel Crockett as CBO
– BlackThorn Therapeutics appointed William Martin as CEO
– Concepta PLC appointed Madeleine Kennedy as CFO and Director
– Covance appointed Paul Kirchgraber as CEO
– Cue Biopharma appointed Anish Suri as president in addition to his current role as CSO
– Dechra Pharmaceuticals PLC announced that Paul Sandland, acting CFO since April this year, has been appointed as an Executive Director and permanent CFO
– Dyne Therapeutics appointed Joshua Brumm as CEO
– Entasis Therapeutics appointed David Altarac as CMO
– Galderma appointed Flemming Ornskov as CEO
– Gilead appointed Andrew Dickinson as CFO and Merdad Parsey, as CMO
– Google appointed Karen DeSalvo as its first Chief Health Officer
– Ipsen appointed Howard Mayer as Executive Vice President and Head of R&D
– IXICO appointed Lammert Albers as CBO – iOmx Therapeutics appointed Apollon Papadimitriou as CEO and Marcus Irsfeld as CFO
– Lilly USA announced that Enrique Conterno is retiring after 27 years; Mike Mason, will take the reins as CEO
– NetScientific plc appointed Ilian Iliev as a Non-Executive Director
– Pfizer announced that Executive Chairman of the Board Ian Read will retire and be replaced by CEO Albert Bourla
– Phathom Pharmaceuticals appointed Terrie Curran as CEO
– Pyxis Oncology appointed Ronald Herbst as CSO
– Qiagen CEO, Peer Schatz has stepped down – Renalytix AI plc appointed Chirag Parikh to the Board
– Rheos Medicines appointed Barbara Fox, Ph.D as CEO
– Roche appointed Matthew Sause as President and CEO
– Scancell Holdings plc appointed Dr Ursula Ney as a Non-Executive Director
– Sensydia Corporation appointed Anthony Arnold as CEO, President and Director
– Smith & Nephew appointed Roland Diggelmann as CEO
– Sonde Health appointed David Liu as CEO – StemoniX has appointed Andrew LaFrence as CFO
– Vertex appointed Reshma Kewalramani as CEO, Carmen Bozic as CMO and Nia Tatsis as CRO
– Verve Therapeutics appointed Andrew Bellinger as CSO
– Xtant Medical Holdings appointed Sean Browne as President and CEO
THIS MONTH’S MOVERS AND SHAKERS
CONSILIUM STRATEGIC COMMUNICATIONS | CITI | COOLEY | STIFEL | INTRADO
ANNUAL HEALTHCARE CONFERENCE 2019
CONNAUGHT ROOMS WC2B
19 NOVEMBER
COMPANY NAMEAMOUNT
RAISEDTYPE OF FUNDRAISE COUNTRY DATE
PUBLIC COMPANY FINANCINGS
Heron Therapeutics Inc $150 million Follow-on US 4-Oct-19
Innovent Biologics Inc $299.8 million Follow-on China 4-Oct-19
Oyster Point Pharma Inc $85 million IPO US 5-Oct-19
Vir Biotechnology $143 million IPO US 10-Oct-19
C4X Discovery Holdings plc £7 million Placing UK 24-Oct-19
argenx $484 million Follow-on Belguim 7-Nov-19
Faron Pharmaceutical Oy £7.48 million Follow-on UK 8-Nov-19
PRIVATE COMPANY FINANCINGS
Molecular Assemblies $12.2 million Series A US 1-Oct-19
STipe Therapeutics $21.9 million Series A Denmark 1-Oct-19
Geneoscopy Inc $6.9 million Series A US 2-Oct-19
Elicio Therapeutics $33 million Series B US 2-Oct-19
Tenaya Therapeutics $92 million Series B US 3-Oct-19
Adicet Bio $80 million Series B US 3-Oct-19
Arcellx Inc. $85 million Series B US 4-Oct-19
Aeovian Pharmacuticals $37 million Series A US 4-Oct-19
3billion Inc. $9.6 million Series B Hong Kong 14-Oct-19
Abalos Therapeutics GmbH $13.2 million Series A Germany 15-Oct-19
Mogrify Ltd $16 million Series A UK 15-Oct-19
Healx $56 million Series B UK 16-Oct-19
Plexium $28 million Series A US 17-Oct-19
Arsenal Biosciences Inc $85 million Series A US 17-Oct-19
Ansun BioPharma Inc $80 million Series B US 17-Oct-19
Arcutis Biotherapeutics Inc $94.5 million Series C US 22-Oct-19
Nuvation Bio $275 million Series A US 28-Oct-19
Disc Medicine $50 million Series A US 29-Oct-19
Sense Biodetection Limited £10.5 million Series A UK 29-Oct-19
Akeso Biopharma Inc. ~$150 million Series C China 30-Oct-19
Pinteon Therapeutics $17 million Series A US 31-Oct-19
Kira Biotech $13.8 million Series A Australia 1-Nov-19
Shasqi Inc. $10 million Series A US 1-Nov-19
Coda Biotherapeutics Inc. $34 million. Series A US 5-Nov-19
A2 Biotherapeutics Inc. $57 million Series A US 6-Nov-19
eGenesis $100 million Series B US 7-Nov-19
Source: BioCentury
HIGHLIGHTED FUNDRAISING ACTIVITY FROM SEPTEMBER TO OCTOBER AND NOVEMBER 2019
CONSILIUM IS PROUD TO BE A MEMBER OF:
INVESTOR CONFERENCE EVENT CALENDAR
NOVEMBERBryan Garnier 2019 Healthcare Conference, Paris (12-13 November)LSX DigiHealth Leaders, London (13-14 November)Stifel Healthcare Conference 2019, New York (13-14 November)Consilium Strategic Communications & Sponsors Healthcare Conference, London (19 November)Inv€$tival Showcase, London (19 November)Jefferies Healthcare Conference, London (20-21 November)Canaccord Genuity Medical Technology and Diagnostics Forum, New York (21 November)
DECEMBERBerenberg Bank Annual European Conference, Surrey (2-5 December)Piper Jaffray Annual Healthcare Conference, New York (3-5 December)Forbes Healthcare Summit, New York (4-5 December)61st ASH Annual Meeting & Exposition, Orlando (7-10 December)
JANUARYSachs 3rd Annual Neuroscience Innovation Forum, San Francisco (12 January)Biotech Showcase, San Francisco (13-15 January)JP Morgan 38th Annual Healthcare Conference, San Francisco (13-16 January)22nd Annual Needham & Co. Growth Conference, New York (14-15 January)
FEBRUARY6th Annual LSX World Congress, London (4-5 February)ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco (6-8 February)Annual BIO CEO & Investor Conference, New York (10-11 February)Sachs13th Annual European Life Sciences CEO Forum, Zurich (19-20 February) Leerink Partners Global Healthcare Conference 2020, New York (25-27 February)
MARCHRaymond James Annual Institutional Investors Conference, Orlando (1 March)Credit Suisse Healthcare One-on-One Conference, London (3-4 March) Morgan Stanley European MedTech & Services Conference, London (5 March)New York BIO Annual Conference, New York (10 March) BIO Asia International Conference, Tokyo (10-11 March)Barclays Capital Healthcare Conference, Miami (10-12 March)Roth Capital Partners Annual Conference, California (15-17 March)Oppenheimer & Co. Annual Healthcare Conference, New York (17-18 March)BIO-Europe Spring, Vienna (23-26 March)Cowen & Co. Annual Health Care Conference, Boston (TBD) ARM Cell & Gene Therapy Investor Day, New York (TBD)KBC Securities Healthcare Conference, Brussels (TBD)
APRILKempen & Co. Life Sciences Conference, Amsterdam (1 April)H.C. Wainwright Global Life Sciences Conference, London (6-7 April)BioCentury Future Leaders in the Biotech Industry, New York (12 April) ARM Cell & Gene Meeting on the Mediterranean, Barcelona (15-17 April)BioTrinity 2020, London (28-29 April)
MAYBank of America Merrill Lynch 2020 Healthcare Conference, Las Vegas (1 May)Deutsche Bank Annual Healthcare Conference, Boston (1 May)ChinaBio Partnering Forum, Suzhou (6-7 May)Citi Swiss Healthcare Day, Zurich (7 May)BioEquity Europe, Barcelona (11-12 May)UBS Global Healthcare Conference, New York (18-20 May) RBC Capital Markets 2020 Healthcare Conference, New York (26-27 May)
JUNEAnglonordic Life Science Conference, London (24 June)
2019
2020
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients,
Boards and advisors
Networked across all critical stakeholders
Europe’s largest specialist team with deep sector knowledge
41 LOTHBURY | LONDON | EC2R 7HG
NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 [email protected] www.consilium-comms.com
@ConsiliumHC
Experts across all sub-sectors of healthcare
